mullerian

mullerian

1. Mullerian inhibiting hormone

MIH

2. Mullerian inhibiting factor deficiency

Muller抑制因子缺乏

3. Mullerian mixed tumor

Muller混合瘤

4. Excision of mullerian duct

Muller管切除术

5. Mullerian duct rest

Muller管残余

6. Mullerian regression factor deficiency

Muller退行因子缺乏

7. Mullerian capsule

[医] 苗勒氏囊, 鲍曼氏囊, 肾小球囊

8. Mullerian duct

[医] 苗勒氏管(副中肾管)

9. Illert B,Sailer M,Gassel AM,et al.Primary extragenital manifestation of a malignant mixed Mullerian tumor of the major omentum. Chirurg,1996，67:1273-1275.

中华医疗保健网是专门介绍保健方法、健康经验、保健资讯、健康生活的精品网站，它能帮助您快乐健康的生活！

10. abnormal fusion of mullerian ducts

中肾旁管融合异常

11. Keywords Glandular inclusion body;Mullerian epithelium;Lymph node;Pelvic and abdominal cavity;

关键词腺体包涵体;苗勒上皮;淋巴结;盆腹腔;

12. Keywords Mullerian duct;Hormone;Genitalia abnormalities;

关键词苗勒管;激素;生殖器;畸形;

13. Keywords mullerian ducts;retroperitoneal tumour;

关键词苗勒管;腹膜后肿瘤;

14. accessory mullerian funnel

副muller漏斗:与原始输卵管相似的痕迹器官

15. Mullerian duct(paramesonephric duct)

副中肾管

16. Mullerian inhibiting hormone(MIH)

副中肾管抑制激素

17. Mullerian regression factor

副中肾管组织退化因子, 米勒管抑制因子

18. mullerian duct syndrome

副中肾管综合征

19. funnel, accessory Mullerian

副苗勒(氏)漏斗

20. Keywords ovarian neoplasms/pathology;ovarian neoplasms/therapy mullerian tumor;EPSPC;

卵巢肿瘤/病理学;卵巢肿瘤/治疗;苗勒氏管肿瘤;EPSPC;

21. HOX genes are involved in the development of the Mullerian system and then continue to be expressed in adult uterus.

在哺乳类HOX基因家族共39个基因,分A、B、C、D四簇位于染色体7,17,12,2的3’端到5’端,分别表达于胚胎的头部到尾部相对应的特定区域。

22. Diagnostic Value of US in Malignant Mixed Mullerian Tumors

女性生殖系统恶性Mullerian混合瘤超声与病理结果对照分析

23. Keywords Uterus;Mullerian duct;Anomalies;Magnetic resonance imaging;Infertility;

子宫;苗勒管;发育异常;磁共振成像;不孕;

24. A Clinical Analysis of 28 Uterine Malignant Mullerian Duct Mixed Tumors

子宫恶性苗勒氏管混合瘤28例临床分析

25. Clinical Analysis on Mullerian Adenosarcoma of The Uterus

子宫苗勒氏腺肉瘤临床初探

26. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma:Three recurrences in 8 months increasing in number and grade of sarcomatous components

子宫苗勒管腺肉瘤晚期复发为异种组织肉瘤:8个月内3次复发且肉瘤样成分的数量增加,组织学分级提高

27. Change of serum mullerian inhibiting substance level and its clinical significance in children

小儿血清苗勒抑制物质水平变化及其临床意义

28. Keywords Malignant mixed mullerian tumors（MMMTs） CA125 diagnosis treatment prognosis;

恶性中胚叶混合瘤;CA125;诊断;治疗;预后;

29. malignant mixed mullerian tumor

恶性米勒管混合瘤

30. Malignant Mullerian duct mixed tumor

恶性苗勒管混合瘤

31. mullerian inhibitor

抑制米勒管物质, 副中肾管抑制物

32. Anti - mullerian hormone

抗苗勒氏管激素

33. anti - mullerian hormone receptor type Ⅱ

抗苗勒氏管激素Ⅱ型受体

34. anti Mullerian hormone

抗苗勒管激素

35. Study on the Anti Mullerian Hormone Served as a Marker for Granulosa Cell Tumorof Ovary

抗苗勒管激素作为卵巢颗粒细胞瘤肿瘤标记物的实验研究

36. [ Abstract] Objective To analyze the clinical features and affecting the prognosis of uterine malignant mixed Mullerian tumor(MMMT).

摘要 目的 探讨子宫恶性苗勒管混合瘤（MMMT）的临床病理特点及影响预后的因素。

37. Mullerian agenesis is the second most common cause of primary amenorrhea after gonadal dysgenesis.

摘要在原发性无月经症当中，苗勒氏管不发育是仅次于性腺发育异常的第二常见原因。

38. Leiomyoma are very common in the normal uterus;however, they are rather rare in mullerian duct remnant.

摘要正常子宫肌肉发生肌瘤是很常见的，然后，在苗勒氏管遗迹长出肌瘤非常罕见。

39. An experimental study was carried out on the Mullerian duct cells, i.e. epithelial cells and stromal cells, treated with trypsin and isolated by Percoll gradient centrifugation. Then they were cultured separately.

本实验应用胰酶消化后的Percoll梯度分离技术,将苗勒管上皮细胞与间质细胞分离开来,然后分别进行细胞培养。

40. We report a case of mullerian duct remnant leiomyoma associated with vaginal agenesis.

本文病例为一阴道发育不良，在苗勒氏管遗迹上长出肌瘤的病例报告。

41. We present a 18-year-old young lady with primary amenorrhea due to mullerian agenesis.

本篇探讨一位十八岁女性，诊断为苗勒氏管不发育之原发性无月经症。

42. persistent mullerian duct syndrome

永久性副中肾管综合征

43. mixed Mullerian tumor

混合副中肾管肿瘤

44. mixed Mullerian sarcoma

混合性副中肾管肉瘤, 混合性中胚叶瘤

45. Excision of cyst of Mullerian duct in male

男性Muller管囊肿切除术

46. Mullerian inhibitory substance

穆勒抑制物

47. Mullerian mimicry The condition where unpalatable species resemble each other, and are recognised and avoided by predators.

穆勒氏拟态不适口的种彼此相似，被掠食者辨认出且避开的状况。

48. mullerian agenesis

米勒管发育不全

49. Mullerian ductogenic transitional cell carcinoma:case report

米勒管源性移行细胞癌1例

50. mullerian remnants

米勒管遗迹

51. Results 1) The rate of misdiagnosis was 70.6%, especially which of leiomyosarcoma was the highest (85.2%)and which of Malignant mullerian mixed tumor is the lowest. (36.4%).

结果 1) 误诊率达70.6%，最常被误诊为子宫肌瘤，平滑肌肉瘤误诊率最高（85.2%），子宫恶性中胚叶混合瘤误诊率最低（36.4%）。

52. Mullerian body

缪(勒)氏体

53. mixed Mullerian tumour

缪勒(氏)管混合瘤, 混合性副中肾管瘤

54. Mullerian mimicry

缪勒拟态

55. Mullerian mimicry - In this type of mimicry two dangerous species evolve the same signaling trait to the mutual benefit of both.

缪勒拟态 -在这两种类型的模拟危险物种进化相同的信号特征，以双方都受益。Compare with Batesian mimicry.比较Batesian模仿。

56. Keywords Endosonography;Mullerian ducts;Ejaculatory ducts;Cysts;

腔内超声检查;苗勒管;射精管;囊肿;

57. Keywords peritoneum tumour mixed mullerian tumor histogenesis histo-pathologic classfication;

腹膜肿瘤;苗勒型混合瘤;组织发生;组织病理学类型;

58. Keywords Peritoneal neoplasms;Mixed tumor;mullerian;

腹膜肿瘤;苗勒混合瘤;

59. Mullerian regression factor, Mullerian duct inhibitory factor

苗勒(氏)(管)退化因子, 苗勒(氏)管抑制因子

60. Mullerian duct cysts

苗勒(氏)副中肾管囊肿

61. Mullerian inhibiting substance

苗勒(氏)抑制物质:胎儿睾丸的滋养细胞所产生的一种糖蛋白, 对控制男性表型的形成起作用

62. Mullerian epithelium

苗勒上皮

63. mullerian inhibiting proteins

苗勒氏抑制蛋白(物)

64. mullerian cyst

苗勒氏管囊肿

65. mullerian tubercle

苗勒氏结节

66. Keywords Mullerian duct abnormalities;HOXA13 gene;hand-foot-genital syndrome （HFGS）;capillary electrophoresis;sequencing analysis;

苗勒管发育异常;HOXA13基因;手-足-生殖器综合征;毛细管电泳;序列分析;

67. Mullerian duct cyst

苗勒管囊肿

68. Keywords Mullerian duct cyst Vasoseminal Vesiculography Tomography;X-ray computed;

苗勒管囊肿;精囊造影;体层摄影术;X线计算机;

69. ER. PR. Vimentin, the results showed that the cancer arose from epithelium of Mullerian duct.

通过形态学、AB/PAS组化染色及EMA、CEA、PR、ER、Vimentin免疫酶标检测，结果证明该癌起自苗勒管上皮，为宫颈腺癌的一种特殊类型。

70. The relationship between mullerian inhibiting substance (MIS) and age in children suffering from non-urogenital disease and cryptorchidism was explored.

通过测定非泌尿生殖系统疾病及隐睾患者的血清苗勒抑制物质(MIS)值,观察年龄与MIS的相关性。